Cargando…

Corrigendum to “Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis”

Detalles Bibliográficos
Autores principales:	Zuo, Didi, Zhang, Jiantao, Liu, Tao, Li, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585668/ https://www.ncbi.nlm.nih.gov/pubmed/33123193 http://dx.doi.org/10.1155/2020/9328192

Ejemplares similares

Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis
por: Zuo, Didi, et al.
Publicado: (2020)

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]
Publicado: (2020)

Corrigendum to “Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis”
Publicado: (2020)

Corrigendum to “Claudin-7 Inhibits Proliferation and Metastasis in Salivary Adenoid Cystic Carcinoma Through Wnt/β-Catenin Signaling”
Publicado: (2021)

Corrigendum to: Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis
por: Saw, Kai Sheng, et al.
Publicado: (2022)

Corrigendum to “The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients after Radical Surgery”
por: Zheng, Kuo, et al.
Publicado: (2020)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

The Blood Biomarkers of Thyroid Cancer [Corrigendum]
Publicado: (2022)

Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer [Corrigendum]
Publicado: (2021)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
Publicado: (2022)

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”
por: Wang, TingAn, et al.
Publicado: (2021)

Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020)

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: Matthews, LH McCormick, et al.
Publicado: (2015)

Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis
por: Li, Chao, et al.
Publicado: (2019)

Corrigendum to “The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer”
por: Yang, Zhiqian, et al.
Publicado: (2023)

Efficacy of bronchoscopic lung volume reduction: a meta-analysis [Corrigendum]
Publicado: (2014)

Corrigendum to “Glutathione Peroxidase Level in Patients with Vitiligo: A Meta-Analysis”
por: Xiao, Bi-huan, et al.
Publicado: (2017)

Corrigendum to: Transfusion-Transmitted Malaria: A Systematic Review and Meta-Analysis
por: Ahmadpour, Ehsan, et al.
Publicado: (2020)

Corrigendum to “XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer”
por: Wang, Wenjun, et al.
Publicado: (2021)

Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Li, Chao, et al.
Publicado: (2019)

Corrigendum to “Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes”
por: Fu, Yuanyuan, et al.
Publicado: (2022)

Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Li, Chao, et al.
Publicado: (2018)

Corrigendum to “Effectiveness of interventions to reduce homelessness: A systematic review and meta‐analysis”
Publicado: (2023)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

Corrigendum to “Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy”
por: Moastafa, Tarek M., et al.
Publicado: (2015)

Corrigendum to The Effect of Acupuncture in Breast Cancer–Related Lymphoedema (BCRL): A Systematic Review and Meta-Analysis
Publicado: (2019)

Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies
por: Oldroyd, Alexander G S, et al.
Publicado: (2021)

Corrigendum to “Efficacy and Safety of Butorphanol Use in Patient-Controlled Analgesia: A Meta-Analysis”
por: Zhu, Zhihua, et al.
Publicado: (2021)

Corrigendum to “Function of N6-Methyladenosine Modification in Tumors”
por: Zhang, Nan, et al.
Publicado: (2023)

Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”
por: Li, Guang, et al.
Publicado: (2021)

Prognostic Role of a New Inflammatory Index with Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase (CII: Colon Inflammatory Index) in Patients with Metastatic Colorectal Cancer: Results from the Randomized Italian Trial in Advanced Colorectal Cancer (ITACa) Study [Corrigendum]
Publicado: (2020)

Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum]
Publicado: (2019)

ACAT2 Promotes Cell Proliferation and Associates with Malignant Progression in Colorectal Cancer [Corrigendum]
Publicado: (2021)

Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
por: Dai, Xiao-Meng, et al.
Publicado: (2017)

Corrigendum to “Fibrinogen as a Prognostic Predictor in Pediatric Patients with Sepsis: A Database Study”
por: Tang, Xiaomeng, et al.
Publicado: (2021)

Corrigendum: Effectiveness of mobile applications to quit smoking: Systematic review and meta-analysis
por: Cobos-Campos, Raquel, et al.
Publicado: (2021)

Corrigendum to: Identifying predictors of ventral hernia recurrence: systematic review and meta-analysis
por: Parker, S G, et al.
Publicado: (2021)

Corrigendum to “High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer”
por: Yang, Long, et al.
Publicado: (2019)

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer [Corrigendum]
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_podveslmtsttrgkq7dh7ed57ji